Device Trial Radar · NCT07648693
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial
Last checked: Nov 19, 2026Latest source record: Jun 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Oct 31, 2025
Primary completion
Sep 30, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Resonova (Shanghai) Medtech LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 15, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, randomized controlled study. The goal of the study is to assess the safety and effectiveness of the Resonova® CHORDS® Cerebral Protection System in capturing and removing embolic debris during Transcatheter Aortic Valve Replacement (TAVR). A total of 240 eligible participants will be enrolled and randomized in a 1:1 ratio to undergo TAVR either with the CHORDS® Cerebral Protection System (Test group) or the Sentinel System (Control group).All the participants will be followed up at 30 days and 90 days post-procedure.
Conditions
- Transcatheter Aortic Valve Replacement (TAVR)
- Cerebral Vascular Accident (CVA)/Stroke
Interventions
CHORDS® Cerebral Protection SystemDevice
Undergo TAVR procedure with the CHORDS® Cerebral Protection System
Sentinel Cerebral Protection SystemDevice
Undergo TAVR procedure with Sentinel Cerebral Protection System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of freedom from Major Adverse Cardiac and Cerebrovascular Events (MACCE)Time frame: 30 days post-procedure
- Total new lesion volume (TLV, mm³) in protected territories(DW-MRI)Time frame: 2-7 days post-procedure
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Zhongshan Hospital, Fudan University
Shanghai, China · Recruiting
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China · Recruiting
Anhui Provincial Hospital
Hefei, Anhui, China · Recruiting
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.